Skip to Content
SBMI Horizontal Logo

Select Papers Published by our Team in Peer-Reviewed Literature 

  1. Bakos-Block C, Yatsco A, Cohen A, Vega F, Champagne-Langabeer T. (2024) “My Addiction Doesn’t  Define Me”—Experiences of Stigma among Mothers with Opioid Use Disorder. Pharmacoepidemiology.  January; 3:57-68. doi: 
  2. Smith NZ, Thornton JD, Fenton SH, Simmons D, Champagne-Langabeer T. (2023) Helpful,  Unnecessary, or Harmful: A Systematic Review of the Effects of Prescription Drug Monitoring Program Use on  Opioid Prescriptions. Pharmacoepidemiology. 2023 December; 2:350-365. doi: 

  1. Lalani K, O'Neal M, Joannou SL, Gopal B, Champagne-Langabeer T. (2023) Helping Frontline Workers  in Texas-A Framework for Resource Development. Int J Environ Res Public Health. Oct 17;20(20). doi:  10.3390/ijerph20206935. PubMed PMID: 37887673; PubMed Central PMCID: PMC10606751. 
  2. Malik A, Vu PD, Cohen AS, Bansal V, Cowan MR, Blazek GM, Champagne-Langabeer T. (2023) "I Just  Don't Feel Heard": A Case Study on Opioid Use Disorder and Pain Management. J Pain Palliat Care  Pharmacother. Dec;37(4):308-313. doi: 10.1080/15360288.2023.2250340. PubMed PMID: 37640434. 
  3. Vu PD, Malik A, Cohen AS, Bansal V, Cowan MR, Blazek GM, Champagne-Langabeer T. (2023)  Shared Decision Making in Acute Pain Management in Patients with Opioid Use Disorder: A Scoping  Review. J Clin Med. May 19;12(10). doi: 10.3390/jcm12103555. 
  4. Bakos-Block C, Nash AJ, Cohen AS, Champagne-Langabeer T. (2022) Experiences of Parents with  Opioid Use Disorder during Their Attempts to Seek Treatment: A Qualitative Analysis. Int J Environ Res  Public Health. Dec 11;19(24). doi: 10.3390/ijerph192416660. 
  5. Bakos-Block CR, Al Rawwad T, Cardenas-Turanzas M, Champagne-Langabeer T. (2022) Contact based  intervention reduces stigma among pharmacy students. Curr Pharm Teach Learn. Dec;14(12):1471-1477. doi:  10.1016/j.cptl.2022.10.002. 
  6. Lalani K, Bakos-Block C, Cardenas-Turanzas M, Cohen S, Gopal B, Champagne-Langabeer T. (2022).  The Impact of COVID-19 on Opioid-Related Overdose Deaths in Texas. International Journal of  Environmental Research and Public Health; 19(21):13796. 
  7. Gottlieb A, Yatsco A, Bakos-Block C, Langabeer JR, Champagne-Langabeer T. (2022). Machine Learning for Predicting Risk of Early Dropout in a Recovery Program for Opioid Use Disorder. Healthcare (Basel);10(2). doi: 10.3390/healthcare10020223. 
  8. Champagne-Langabeer T, Cardenas-Turanzas M, Ugalde IT, Bakos-Block C, Stotts AL, Cleveland L, Shoptaw S, Langabeer JR. (2022). The Impact of Pediatric Opioid-Related Visits on U.S. Emergency Departments. Children;9(4). doi: 10.3390/children9040524. 
  9. Gottlieb A, Bakos-Block C, Langabeer JR, Champagne-Langabeer T. (2022). Sociodemographic and Clinical Characteristics Associated with Improvements in Quality of Life for Participants with Opioid Use Disorder. Healthcare (Basel), 16;10(1). doi: 10.3390/healthcare10010167 
  10. Champagne-Langabeer T, Swank MW, Manas S, Si Y, Roberts K (2021). Dramatic Increases in Telehealth-Related Tweets during the Early COVID-19 Pandemic: A Sentiment Analysis. Healthcare (Basel). May 27;9(6). doi: 10.3390/healthcare9060634. PubMed PMID: 34071822.
  11. Langabeer JR, Champagne-Langabeer T, Yatsco AJ, O'Neal MM, Cardenas-Turanzas M, Prater S, Luber S, Stotts A, Fadial T, Khraish G, Wang H, Bobrow BJ, Chambers KA (2021). Feasibility and outcomes from an integrated bridge treatment program for opioid use disorder. J Am Coll Emerg Physicians Open;  2(2):e12417. doi: 10.1002/emp2.12417. 
  12. Li Z, Du X, Liao X, Jiang X, Champagne-Langabeer T (2021). Demystifying the Dark Web Opioid Trade: Content Analysis on Anonymous Market Listings and Forum Posts. J Med Internet Res. 2021 Feb 17;23(2):e24486. doi: 10.2196/24486. 
  13. Bauer C, Champagne-Langabeer T, Bakos-Block C, Zhang K, Persse D, Langabeer JR. (2021). Patterns and risk factors of opioid-suspected EMS overdose in Houston metropolitan area, 2015-2019: A Bayesian spatiotemporal analysis. PLoS One;16(3):e0247050. doi: 10.1371/journal.pone.0247050. 
  14. Bakos-Block C, Langabeer JR, Yatsco A, Cardenas-Turanzas M, Champagne-Langabeer T (2020). Prevalence of Mental Health Disorders among Individuals Enrolled in an Emergency Response Program for Treatment of Opioid Use Disorder. Substance Abuse. 2020;14:1178221820981998. doi:  10.1177/1178221820981998 
  15. Langabeer JR, Stotts AL, Bobrow BJ, Wang HE, Chambers KA, Yatsco AJ, Cardenas-Turanzas M, Champagne-Langabeer T (2021). Prevalence and charges of opioid-related visits to U.S. emergency departments. Drug Alcohol Dependence. Apr 1;221:108568. doi: 10.1016/j.drugalcdep.2021.108568
  16. Langabeer JR 2nd, Yatsco A, Champagne-Langabeer T. Telehealth sustains patient engagement in OUD treatment during COVID-19. J Subst Abuse Treat. 2020 Nov 24;:108215. doi:

10.1016/j.jsat.2020.108215. [Epub ahead of print] PubMed PMID: 33248863; PubMed Central PMCID:  PMC7685137. 

  1. Champagne-Langabeer T, Bakos-Block C, Yatsco A, Langabeer JR. (2020). Emergency medical services targeting opioid user disorder: An exploration of current out?of?hospital post?overdose interventions. JACEP Open. (Epub ahead of print):1-10. doi: 
  2. Yatsco AJ, Garza RD, Champagne-Langabeer T, Langabeer JR. Alternatives to Arrest for Illicit Opioid Use: A Joint Criminal Justice and Healthcare Treatment Collaboration. Subst

Abuse. 2020;14:1178221820953390. doi: 10.1177/1178221820953390. 

  1. Yatsco AJ, Champagne-Langabeer T, Holder T, Stotts A, Langabeer JR. (2020). Developing Interagency  Collaboration to Address the Opioid Epidemic: A Scoping Review of Joint Criminal Justice and Healthcare  Initiatives. International Journal of Drug Policy; 83:102849. doi: 10.1016/j.drugpo.2020.102849. 
  2. Langabeer J, Stotts A, Cortez C, Tortolero G, Champagne-Langabeer T. (2020). Geographic Proximity to  Buprenorphine Treatment Providers in the U.S. Drug and Alcohol Dependence. 24;213:108131. doi:  10.1016/j.drugalcdep.2020.108131. PubMed PMID: 32599495. 
  3. Langabeer JR, Persse D, Yatsco A, O'Neal MM, Champagne-Langabeer T. (2020). A Framework for EMS Outreach for Drug Overdose Survivors: A Case Report of the Houston Emergency Opioid Engagement System. Prehospital Emergency Care;1-8. doi: 10.1080/10903127.2020.1755755. PubMed PMID: 32286893. 
  4. Langabeer J, Chambers K, Cardenas-Turanzas M, Champagne-Langabeer T. (2020). County-Level  Factors Underlying Opioid Mortality in the United States. Substance Abuse. 18:1-7. doi:  10.1080/08897077.2020.1740379. PubMed PMID: 32186475.
  5. Champagne-Langabeer T, Swank MW, Langabeer JR 2nd. (2020). Routes of non-traditional entry into buprenorphine treatment programs. Substance Abuse Treatment, Prevention, and Policy. Jan 20;15(1):6. doi: 10.1186/s13011-020-0252-z. Review. PubMed PMID: 31959194; PubMed Central PMCID: PMC6972002. 
  6. Langabeer J, Champagne-Langabeer T, Luber S, Prater S, Stotts, Kirages K, Yatsco A, Chambers, K. (2019). Outreach to People Who Survive Opioid Overdose: Linkage and Retention in Treatment. J Subst Abuse Treat. 2020 Apr;111:11-15. doi: 10.1016/j.jsat.2019.12.008. Epub 2019 Dec 24. PubMed PMID: 32087833. 
  7. Champagne-Langabeer T, Madu R, Giri S, Stotts AL, Langabeer, JR. (2019). Opioid prescribing patterns and overdose deaths in Texas. Substance Abuse.
  8. Langabeer J, Chambers K, Persse D, Yatsco A, Champagne-Langabeer T. (2019). Houston ED Opioid  System Integrates Assertive Outreach with Comprehensive Care for Opioid Use Disorder. Journal of the  Emergency Medical Services, [Epub ahead of print] 
  9. Langabeer J, Champagne-Langabeer T, Gleisberg G, Persse D, Gonzalez M. (2019). Tele-EMS Improves  Productivity and Reduces Overall Cost. Journal of the Emergency Medical Services,  
  10. Langabeer JR, Gourishankar A, Chambers KA, Giri S, Madu R, Champagne-Langabeer T. (2019). Disparities Between US Opioid Overdose Deaths and Treatment Capacity: A Geospatial and Descriptive Analysis. Journal of Addiction Medicine, 13(6), 476–482.

Select National and State Presentations from our Team 

Malik, Aila; Champagne-Langabeer, Tiffany. Opioid Use Disorder Recovery Journey in the setting of Acute  Pain: A Case Study. American Academy of Pain Medicine 2023. Fort Lauderdale, FL. March 23-26, 2023. 

Yatsco, A. (2022, August). Science of Substance Use, Medication Assisted Treatment, & Challenging Stigma.  1.0 CEU Presentation at Texas Grand Rounds hosted by the Opioid Response Network. 

Yatsco, A., Kuhn, K. (2022, August). UT Health Heroes: Overdose response strategy. 0.5 CEU Oral  Presentation at 13th Annual Community Drug Awareness Day Conference hosted by Houston Harris County  Office of Drug Control Policy Committee. Houston, TX. 

Yatsco, A., Cleveland, L., Sledge, D., Burwell, A., & Velasquez, C. (2022, March). Leveraging paramedicine  teams to solve the U.S. overdose epidemic. 2.0 CEU Oral presentation at Texas Substance Use Symposium  (TxSUS) Annual Conference. Corpus Christi, TX.  

Champagne-Langabeer, T. (2022). Reducing Stigma through Interprofessional Education. McGovern School of  Medicine Grand Rounds, Department of Psychiatry. March 8, 2022.  

Bakos-Block, C., Champagne-Langabeer, T. (2021). Addressing the Opioid Crisis Through Community  Engagement: Houston Emergency Opioid Engagement System (HEROES) - 

Clinical Case Presentation, AMERSA. November 4, 2021. 

Thornton JD, Al Rawwad T, Bakos-Block C, Nania C, Champagne-Langabeer, T. (2021). Reducing opioid use  disorder related stigma among pharmacy students using contact-based education. Stigma of Addictions Summit,  Dell Medical School, Austin, Texas June 10, 2021.  

Champagne-Langabeer T, Langabeer J. (2020). Assessing Prevalence of Co-Occurring Mental Health Disorders  in Non-Fatal Overdose Survivors. International Conference on Opioids (Virtual), August 3-4, 2020. 

Langabeer J, Champagne-Langabeer T, Prater S, Luber S, Fadial T, Yatsco A, Khraish G, Bobrow B, Chambers  K (2020). Emergency Department-initiated Outreach and Treatment for Opioid Use Disorders. Society for  Academic Emergency Medicine, Annual Meeting, Denver CO, May 12, 2020. 

Langabeer J, Yatsco A, Chambers K, Champagne-Langabeer T (2020). Access to Emergency Opioid Treatment  Improves Community Resilience and Patient Outcomes for High-Risk Opioid Users in Houston. Rx Drug Abuse  and Heroin Summit, Nashville TN, April 13, 2020. 

Yatsco A, Champagne-Langabeer T, Garza R, Langabeer J. (2020). Alternatives to Arrest for Illicit Opioid Use:  A Joint Criminal Justice and Healthcare Treatment Collaboration. Academy of Criminal Justice Sciences Annual  Meeting, San Antonio TX March 25, 2020. 

Langabeer J, Champagne-Langabeer T, Yatsco A, Chambers K. (2019). A Comprehensive Community Program  Tackling Opioid Abuse in Houston. Healthier Texas Summit, Austin TX October 17, 2019. 

Langabeer J, Chambers K, Champagne-Langabeer T. (2019). Preliminary Results from a Post-Overdose  Outreach and Emergency Department-Initiated Opioid Initiative. International Conference on Opioids. Harvard  Medical School, Boston, Mass June 9, 2019.